More Than $3.3 Billion in Pharma-Biotech Planned for China in Fourth Quarter, an Industrial Info Market Brief
More Than $3.3 Billion in Pharma-Biotech Planned for China in Fourth Quarter, an Industrial Info Market Brief
Attachment: kickoff 201909
Industrial Info is tracking 88 projects in China's Pharma-Biotech Industry, worth $3.34 billion, that are set to begin construction in fourth-quarter 2019. Click here for a list. The Jiangsu, Anhui and Zhejiang provinces lead in overall investment, which includes projects for active pharmaceutical ingredients, final formulation, laboratories and medical devices.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021